BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30171988)

  • 1. PIGU overexpression adds value to TNM staging in the prognostic stratification of patients with hepatocellular carcinoma.
    Cao J; Wang P; Chen J; He X
    Hum Pathol; 2019 Jan; 83():90-99. PubMed ID: 30171988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PIGU promotes hepatocellular carcinoma progression through activating NF-κB pathway and increasing immune escape.
    Wei X; Yang W; Zhang F; Cheng F; Rao J; Lu L
    Life Sci; 2020 Nov; 260():118476. PubMed ID: 32971102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of cytoskeleton-associated membrane protein 4 and its palmitoyl acyltransferase DHHC2 in hepatocellular carcinoma.
    Li SX; Tang GS; Zhou DX; Pan YF; Tan YX; Zhang J; Zhang B; Ding ZW; Liu LJ; Jiang TY; Hu HP; Dong LW; Wang HY
    Cancer; 2014 May; 120(10):1520-31. PubMed ID: 24863391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low levels of glycoprotein 96 indicate a worse prognosis in early-stage hepatocellular carcinoma patients after hepatectomy.
    Ji F; Zhang Y; Zhu ZB; Guo Y; Shen SL; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
    Hum Pathol; 2019 Apr; 86():193-202. PubMed ID: 30529751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma.
    Guo X; Xiong L; Sun T; Peng R; Zou L; Zhu H; Zhang J; Li H; Zhao J
    Diagn Pathol; 2012 Apr; 7():44. PubMed ID: 22515642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ITPKA expression is a novel prognostic factor in hepatocellular carcinoma.
    Li J; Zhu YH; Huang P; Zhang B; Sun J; Guan XY
    Diagn Pathol; 2015 Aug; 10():136. PubMed ID: 26249031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma.
    Wang JH; Wei W; Xu J; Guo ZX; Xiao CZ; Zhang YF; Jian PE; Wu XL; Shi M; Guo RP
    Oncotarget; 2015 Oct; 6(33):35116-28. PubMed ID: 26375669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of retinoic acid-induced protein 3 predicts poor prognosis for hepatocellular carcinoma.
    Zheng J; Guo X; Gao X; Liu H; Tu Y; Zhang Y
    Clin Transl Oncol; 2014 Jan; 16(1):57-63. PubMed ID: 23632812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification.
    Zhang Y; Fan Y; Mei Z
    Cancer Epidemiol; 2012 Oct; 36(5):e294-9. PubMed ID: 22728279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canopy Homolog 2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma with Tumor Hemorrhage.
    Wang D; Wang ZM; Zhang S; Wu HJ; Tao YM
    Cell Physiol Biochem; 2018; 50(6):2017-2028. PubMed ID: 30415246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cullin1 is up-regulated and associated with poor patients' survival in hepatocellular carcinoma.
    Liu W; Wang Y; Zhang C; Huang B; Bai J; Tian L
    Int J Clin Exp Pathol; 2015; 8(4):4001-7. PubMed ID: 26097587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma.
    Li L; Xu L; Yan J; Zhen ZJ; Ji Y; Liu CQ; Lau WY; Zheng L; Xu J
    J Exp Clin Cancer Res; 2015 Oct; 34():129. PubMed ID: 26503598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.
    Ji F; Fu SJ; Shen SL; Zhang LJ; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
    BMC Cancer; 2015 Mar; 15():116. PubMed ID: 25880619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients.
    Wang P; Guo L; Li K; Ning S; Shi W; Liu Z; Chen Y
    Cancer Biomark; 2018 Feb; 21(3):681-687. PubMed ID: 29278882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients.
    Ding Y; Chen B; Wang S; Zhao L; Chen J; Ding Y; Chen L; Luo R
    Int J Cancer; 2009 Feb; 124(3):653-8. PubMed ID: 18972435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
    Shi XM; Teng F
    Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of N-acetyltransferase 10: a novel independent prognostic marker of worse outcome in patients with hepatocellular carcinoma.
    Zhang X; Liu J; Yan S; Huang K; Bai Y; Zheng S
    Int J Clin Exp Pathol; 2015; 8(11):14765-71. PubMed ID: 26823802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of ARID4B predicts poor survival in patients with hepatocellular carcinoma.
    Wang R; Yu Z; Chen F; Liao C; Wang Q; Huang X
    Hum Pathol; 2018 Mar; 73():114-121. PubMed ID: 29288040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.